MGB Biopharma Announces Completion of Funding Round

MGB Biopharmaa biopharmaceutical company developing a novel class of anti-infectives to address the major global problem of antibiotic resistance, has completed its latest funding round.

The over-subscribed fund-raise was supported by new and existing investors, led by Archangel Investors and including Scottish Investment Bank (the investment arm of Scottish Enterprise, Scotland’s national economic development agency), Barwell and TriCapital Investors.

The new funding will allow the company to complete all activities around its ongoing Phase IIa clinical trial with its lead antibiotic MGB-BP-3 and prepare for the next stages of its development and to progress other programmes through to H2 2020. 

Dr Miroslav Ravic, CEO of MGB Biopharma, said: “We are delighted to have secured additional financing from both new and existing investors, who have demonstrated their confidence in the progress of our Phase IIa study. Given its unique properties, we remain confident that MGB-BP-3 could become a new paradigm for the treatment of CDAD, a potentially life-threatening infection.”

Dr Sarah Hardy, Chief Investment Officer at Archangels, said: “There remains a desperate need for novel treatments in our armoury to treat C. difficile infections.  The work that MGB Biopharma is undertaking is both important and innovative and the results that have been achieved so far have been very encouraging.”

Kerry Sharp, Director of Scottish Investment Bank, said: “Scotland hosts one of the most sizeable and vibrant life sciences communities in Europe. As one of those community companies, MGB Biopharma is at an exciting stage as it progresses through its Phase IIa clinical trial.”

The Company acknowledges the support to the funding of its Phase IIa trial with MGB-BP-3 from an award from Innovate UK, the Biomedical Catalyst Fund. The Company also acknowledges the support of University of Strathclyde where MGB-BP-3 was discovered and initially developed.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Sponsor

Our Other Titles

Latest

Bellrock Technology announce new chairman and £1 million investment

GLASGOW-based Bellrock Technology has appointed Steve Langmead as its new chairman as the data analytics company gears up for a landmark year...

Perth eco-development takes a step closer

SCOTLAND’S largest carbon-neutral development, Perth West, has taken a step closer as the full planning application has been submitted.

Telecoms chairman says more investment needed to help a more inclusive post-Covid 19 economy

THE new chairman of telecoms provider Commsworld says the UK must invest heavily in digital technology and infrastructure if it wants to build a...

Edinburgh fintech Aveni seals £520,000 backing

EDINBURGH-based fintech Aveni has secured seed investment of £520,000 for its video conferencing based AI technology, which it claims will transform client interaction in financial...

Law firm names new partners to help strengthen its team

LAW firm Addleshaw Goddard has recruited two new partners to join its Infrastructure Projects & Energy Practice (IPE). Suzanne Moir, a former...